The Impact of HLA and KIR Ligand Mismatching on Unrelated Allogeneic Hematopoietic Stem Cell Transplantation in Korean Adult Patients
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: The impact of HLA and KIR ligand mismatching on the outcome of hematopoietic stem cell transplantation (HSCT) remains unclear. Previous reports have identified considerable ethnic differences in the impact of HLA and KIR ligand mismatches, as well as KIR ligand status, on HSCT; however, to date, no data has been acquired in Korean adult patients. Methods: We investigated the association of high-resolution HLA matching on five loci (HLA-A, -B, -C, -DRB1, and -DQB1), KIR ligand mismatching, and KIR ligand status on the outcome of allogeneic HSCT from unrelated donors in 154 Korean adult patients treated at Seoul National University Hospital. Results: In a multivariate analysis, less than 9/10 allelic matches in five HLA loci was an independent risk factor for acute graft-versus-host disease (GVHD) (grade II to IV) (P=0.019, odds ratio [OR]=2.7). In addition, HLA-A allele mismatching was increasingly prevalent in patients with acute GVHD compared to patients without (61.9% vs. 34.5%, P=0.06). For KIR ligand status, the patient and donor combination of both C1/C1 ligands showed better event-free and overall survival than combinations with C2 ligand patients or donors (P=0.048, P=0.034, respectively) by log-rank test. Conclusions: Korean adult transplant patients with less than 9 of 10 HLA allele matches in the HLA-A, -B, -C, -DRB1, and DQB1 loci have a higher likelihood of developing acute GVHD (grade II to IV). Impact of KIR ligand status on clinical outcome should be further studied in a larger patient population.
Abstract
Background: The impact of HLA and KIR ligand mismatching on the outcome of hematopoietic stem cell transplantation (HSCT) remains unclear. Previous reports have identified considerable ethnic differences in the impact of HLA and KIR ligand mismatches, as well as KIR ligand status, on HSCT; however, to date, no data has been acquired in Korean adult patients. Methods: We investigated the association of high-resolution HLA matching on five loci (HLA-A, -B, -C, -DRB1, and -DQB1), KIR ligand mismatching, and KIR ligand status on the outcome of allogeneic HSCT from unrelated donors in 154 Korean adult patients treated at Seoul National University Hospital. Results: In a multivariate analysis, less than 9/10 allelic matches in five HLA loci was an independent risk factor for acute graft-versus-host disease (GVHD) (grade II to IV) (P=0.019, odds ratio [OR]=2.7). In addition, HLA-A allele mismatching was increasingly prevalent in patients with acute GVHD compared to patients without (61.9% vs. 34.5%, P=0.06). For KIR ligand status, the patient and donor combination of both C1/C1 ligands showed better event-free and overall survival than combinations with C2 ligand patients or donors (P=0.048, P=0.034, respectively) by log-rank test. Conclusions: Korean adult transplant patients with less than 9 of 10 HLA allele matches in the HLA-A, -B, -C, -DRB1, and DQB1 loci have a higher likelihood of developing acute GVHD (grade II to IV). Impact of KIR ligand status on clinical outcome should be further studied in a larger patient population.
참고문헌 (30)
- Perez LE, "Outcomes from unrelated donor hematopoietic stem cell transplantation", Cancer Control, 18, pp.216~221 (2011)
- Shaw BE, "The impact of HLA genotyping on survival following unrelated donor haematopoietic stem cell transplantation", Br J Haematol, 150, pp.251~258 (2010)
- Ruggeri L, "Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants", Science, 295, pp.2097~2100 (2002)
- Malmberg KJ, "KIR-ligand mismatch in allogeneic hematopoietic stem cell transplantation", MolImmunol, 42, pp.531~534 (2005)
- Ruggeri L, "Natural killer cell alloreactivity in allogeneic hematopoietic transplantation", CurrOpinOncol, 19, pp.142~147 (2007)
- Petersdorf EW, "Clinical significance of donor-recipient HLA matching on survival after myeloablative hematopoietic cell transplantation from unrelated donors", Tissue Antigens, 69(S1), pp.S25~30 (2007)
- Morishima Y, "Effect of HLA-A2 allele disparity on clinical outcome in hematopoietic cell transplantation from unrelated donors", Tissue Antigens, 69(S1), pp.S31~35 (2007)
- Lee KW, "Allelic and haplotypic diversity of HLA-A, -B, -C, -DRB1, and -DQB1 genes in the Korean population", Tissue Antigens, 65, pp.437~447 (2005)
- Yang JH, "Anthropological analysis of Koreans using HLA class II diversity among East Asians", Tissue Antigens, 76, pp.282~288 (2010)
- Farag SS, "Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect", Blood, 100, pp.1935~1947 (2002)
- Giebel S, "Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors", Blood, 102, pp.814~819 (2003)
- Glucksberg H, "Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors", Transplantation, 18, pp.295~304 (1974)
- Gratwohl A, "The EBMT risk score", Bone Marrow Transplant, 47, pp.749~756 (2012)
- Morishima Y, "The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors", Blood, 99, pp.4200~4206 (2002)
- Kawase T, "High-risk HLA allele mismatch combinations responsible for severe acute graft-versus-host disease and implication for its molecular mechanism", Blood, 110, pp.2235~2241 (2007)
- Lee SJ, "High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation", Blood, 110, pp.4576~4583 (2007)
- Hsu KC, "KIR ligands and prediction of relapse after unrelated donor hematopoietic cell transplantation for hematologic malignancy", Biol Blood Marrow Transplant, 12, pp.828~836 (2006)
- Giebel S, "Homozygosity for human leucocyte antigen-C ligands of KIR2DL1 is associated with increased risk of relapse after human leucocyte antigen-C-matched unrelated donor haematopoietic stem cell transplantation", Br J Haematol, 131, pp.483~486 (2005)
- Fischer JC, "Relevance of C1 and C2 epitopes for hemopoietic stem cell transplantation: role for sequential acquisition of HLA-C-specific inhibitory killer Ig-like receptor", J Immunol, 178, pp.3918~3923 (2007)
- Fischer JC, "The impact of HLA-C matching depends on the C1", C2 KIR ligand status in unrelated hematopoietic stem cell transplantation, 2012, pp.64, 879~885
- Ludajic K, "KIR genes and KIR ligands affect occurrence of acute GVHD after unrelated, 12", 12 HLA matched, hematopoietic stem cell transplantation, 2009, pp.44, 97~103
- Gagne K, "Donor KIR3DL1", 3DS1 gene and recipient Bw4 KIR ligand as prognostic markers for outcome in unrelated hematopoietic stem cell transplantation, 2009, pp.15, 1366~1375
- Miller JS, "Missing KIR ligands are associated with less relapse and increased graft-versus-host disease (GVHD) following unrelated donor allogeneic HCT", Blood, 109, pp.5058~5061 (2007)
- Farag SS, "The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the center for international blood and marrow transplant research, the European blood and marrow transplant registry, and the Dutch registry", Biol Blood Marrow Transplant, 12, pp.876~884 (2006)
- Willemze R, "Is there an impact of killer cell immunoglobulin-like receptors and KIR-ligand incompatibilities on outcomes after unrelated cord blood stem cell transplantation?", Best Pract Res ClinHaematol, 23, pp.283~290 (2010)
- Hollenbach JA, "IHIW: population global distribution of killer immunoglobulin-like receptor (KIR) and ligands", Int J Immunogenet, 40, pp.39~45 (2013)
- Shilling HG, "Genetic control of human NK cell repertoire", J Immunol, 169, pp.239~247 (2002)
- Nguyen S, "NK-cell reconstitution after haploidentical hematopoietic stem-cell transplantations: immaturity of NK cells and inhibitory effect of NKG2A override GvL effect", Blood, 105, pp.4135~4142 (2005)
- Stern M, "Natural killer-cell KIR repertoire reconstitution after haploidentical SCT", Bone Marrow Transplant, 45, pp.1607~1610 (2010)
- Parham P. Immunology, "Immunology.NK cells lose their inhibition", Science, 305, pp.786~787 (2004)